Function of cancer cell-derived extracellular matrix in tumor progression

Abstract

Extracellular matrix (ECM) is an essential component of the tumor microenvironment. Cancer development and progression are associated with increased ECM deposition and crosslink. The chemical and physical signals elicited from ECM are necessary for cancer cell proliferation and invasion. It is well recognized that stromal cells are a major source of ECM proteins. However, recent studies showed that cancer cells are also an active and important component in ECM remodeling. Cancer cells deposit a significant amount of collagen, fibronectin, and tenascin C (TNC). Recent studies demonstrate that these cancer cell-derived ECM proteins enhance cancer cell survival and promote cancer cell colonization at distant sites. ECM-related enzymes and chaperone proteins, such as prolyl-4-hydroxylase, lysyl-hydroxylase, lysyl oxidase, and heat shock protein 47, are also highly expressed in cancer cells. Inhibition of these enzymes significantly reduces cancer growth, invasion, and metastasis. These factors suggest that the cancer cell-derived ECM is crucial for cancer progression and metastasis. Therefore, targeting these ECM proteins and ECM-related enzymes is a potential strategy for cancer treatment.

Keywords

Tumor microenvironment / extracellular matrix / cancer progression / metastasis

References

[1] Bissell MJ.Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression..Nat Med2011;17:320-9 PMCID:PMC3569482

[2] Zhu J,Trinkle C.Integrated extracellular matrix signaling in mammary gland development and breast cancer progression..Histol Histopathol2014;29:1083-92

[3] Spencer VA,Bissell MJ.Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress..Adv Cancer Res2007;97:275-94

[4] Xu R,Bissell MJ.Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices..Cancer Metastasis Re2009;28:167-76 PMCID:PMC2720096

[5] Xu R,Muschler JL,Vonderhaar BK.Sustained activation of STAT5 is essential for chromatin remodeling and maintenance of mammary-specific function..J Cell Biol2009;184:57-66 PMCID:PMC2615090

[6] Cox TR.Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer..Dis Model Mech2011;4:165-78 PMCID:PMC3046088

[7] Lu P,Werb Z.The extracellular matrix: a dynamic niche in cancer progression..J Cell Biol2012;196:395-406 PMCID:PMC3283993

[8] Oskarsson T.Extracellular matrix players in metastatic niches..EMBO J2012;31:254-6 PMCID:PMC3261570

[9] Pickup MW,Weaver VM.The extracellular matrix modulates the hallmarks of cancer..EMBO Rep2014;15:1243-53 PMCID:PMC4264927

[10] Canty EG.Procollagen trafficking, processing and fibrillogenesis..J Cell Sci2005;118:1341-53

[11] Lochter A.Involvement of extracellular matrix constituents in breast cancer..Semin Cancer Biol1995;6:165-73

[12] Provenzano PP,Campbell JM,White JG.Collagen reorganization at the tumor-stromal interface facilitates local invasion..BMC Med2006;26:438

[13] Provenzano PP,Eliceiri KW,Yan L,White JG.Collagen density promotes mammary tumor initiation and progression..BMC Med2008;6:11 PMCID:PMC2386807

[14] Aguilera KY,Hur H,Toombs JE,Dellinger MT,Brekken RA.Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma..Cancer Res2014;74:1032-44 PMCID:PMC3944405

[15] Götte M.Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective..Cancer Res2006;66:10233-7

[16] Kii I,Li M,Saito M,Kudo A.Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture..J Biol Chem2010;285:2028-39 PMCID:PMC2804360

[17] Malanchi I,Susanto E,Lehr HA,Huelsken J.Interactions between cancer stem cells and their niche govern metastatic colonization..Nature2012;481:85-9

[18] Oskarsson T,Zhang XH,Tavazoie SF,Downey RJ,Brogi E.Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs..Nat Med2011;17:867-74 PMCID:PMC4020577

[19] Karagiannis GS,Erdman SE,Riddell RH.Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue..Mol Cancer Res2012;10:1403-18 PMCID:PMC4399759

[20] Naba A,Hoersch S,Carr SA.The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices..Mol Cell Proteomics2012;11:M111.014647

[21] Naba A,Lamar JM,Hynes RO.Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters..Elife2014;3:e01308

[22] Calabro A,Hascall VC.Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients..Blood2002;100:2578-85

[23] Kimata K,Okayama M,Hozumi M.Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential..Cancer Res1983;43:1347-54

[24] Patarroyo M,Virtanen I.Laminin isoforms in tumor invasion, angiogenesis and metastasis..Semin Cancer Biol2002;12:197-207

[25] Pyke C,Kallunki P,Ralfkiaer E,Tryggvason K.The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers..Am J Pathol1994;145:782-91

[26] Seftor RE,Koshikawa N,Gardner LM,Stetler-Stevenson WG,Hendrix MJ.Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma..Cancer Res2001;61:6322-7

[27] Zhang L,Chen L.Hyaluronan on the surface of tumor cells is correlated with metastatic behavior..Cancer Res1995;55:428-33

[28] Iseri OD,Arpaci F.Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins..Cancer Chemother Pharmacol2010;65:447-55

[29] Erler JT,Nicolau M,Kong C,Chi JT,Giaccia AJ.Lysyl oxidase is essential for hypoxia-induced metastasis..Nature2006;440:1222-6

[30] Gilkes DM,Wong CC,Hubbi ME,Semenza GL.Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis..Mol Cancer Res2013;11:456-66 PMCID:PMC3656974

[31] Gilkes DM,Bajpai S,Wei H,Hubbi ME,Semenza GL.Collagen prolyl hydroxylases are essential for breast cancer metastasis..Cancer Res2013;73:3285-96 PMCID:PMC3674184

[32] Xiong G,Zhu J,Xu R.Prolyl-4-hydroxylase alpha subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition..BMC cancer2014;14:1 PMCID:PMC3880410

[33] Zhu J,Fu H,Zhou BP.Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network..Cancer Res2015;75:1580-91 PMCID:PMC4401637

[34] Guo W.Integrin signalling during tumour progression..Nat Rev Mol Cell Biol2004;5:816-26

[35] Paulsson M.Basement membrane proteins: structure, assembly, and cellular interactions..Crit Rev Biochem Mol Biol1992;27:93-127

[36] Laurila P.Basement membrane and interstitial matrix components form separate matrices in heterokaryons of PYS-2 cells and fibroblasts..J Cell Sci1993;104:59-68

[37] Egeblad M,Weaver VM.Dynamic interplay between the collagen scaffold and tumor evolution..Curr Opin Cell Biol2010;22:697-706 PMCID:PMC2948601

[38] Knott L.Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance..Bone1998;22:181-7

[39] Gorres KL.Prolyl 4-hydroxylase..Crit Rev Biochem Mol Biol2010;45:106-24 PMCID:PMC2841224

[40] Kukkola L,Kivirikko KI.Identification and characterization of a third human, rat, and mouse collagen prolyl 4-hydroxylase isoenzyme..J Biol Chem2003;278:47685-93

[41] Valtavaara M,Szpirer J.Primary structure, tissue distribution, and chromosomal localization of a novel isoform of lysyl hydroxylase (lysyl hydroxylase 3)..J Biol Chem1998;273:12881-6

[42] van der Slot AJ,Bardoel AF,Pruijs HE,Brinckmann J,Black CM,DeGroot J,TeKoppele JM,Bank RA.Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis..J Biol Chem2003;278:40967-72

[43] Erler JT,Cox TR,Bird D,Le QT.Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche..Cancer cell2009;15:35-44 PMCID:PMC3050620

[44] Kagan HM.Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell..J Cell Biochem2003;88:660-72

[45] Koide T,Yorihuzi T.Conformational requirements of collagenous peptides for recognition by the chaperone protein HSP47..J Biol Chem2000;275:27957-63

[46] Nagata K.Hsp47: a collagen-specific molecular chaperone..Trends Biochem Sci1996;21:22-6

[47] Tasab M,Bulleid NJ.Sequence-specific recognition of collagen triple helices by the collagen-specific molecular chaperone HSP47..J Biol Chem2002;277:35007-12

[48] Bignon M,Hardouin J,Brechot N,Barret A,Guillon E,Caron M,Monnot C,Muller L.Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane..Blood2011;118:3979-89

[49] Cox TR,Baker AM,Ho MW,Erler JT.LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis..Cancer Res2013;73:1721-32 PMCID:PMC3672851

[50] Gilkes DM,Chaturvedi P,Semenza GL.Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts..J Biol Chem2013;288:10819-29 PMCID:PMC3624462

[51] Gilkes DM,Wirtz D.Hypoxia and the extracellular matrix: drivers of tumour metastasis..Nat Rev Cancer2014;14:430-9 PMCID:PMC4283800

[52] Kim BG,Kang S,Gao MQ,Cho NH.Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer..Am J Pathol2011;178:373-81 PMCID:PMC3069863

[53] Lee S,Nagtegaal I,Wu Y,Medina D.Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer..Cancer Res2012;72:4574-86 PMCID:PMC3899801

[54] Levental KR,Kass L,Egeblad M,Fong SF,Giaccia A,Yamauchi M,Weaver VM.Matrix crosslinking forces tumor progression by enhancing integrin signaling..Cell2009;139:891-906 PMCID:PMC2788004

[55] Park J.Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition..Oncogene2014;33:1649-57 PMCID:PMC3934944

[56] Cook AC,Turley EA.Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy..J Biol Chem2006;281:24381-9

[57] Toole BP.Hyaluronan: from extracellular glue to pericellular cue..Nat Rev Cancer2004;4:528-39

[58] Yu Q,Stamenkovic I.Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function..J Exp Med1997;186:1985-96 PMCID:PMC2199167

[59] Conklin MW,Riching KM,Eliceiri KW,Friedl A.Aligned collagen is a prognostic signature for survival in human breast carcinoma..Am J Pathol2011;178:1221-32 PMCID:PMC3070581

[60] Iyengar P,Williams TW,Berry D,Lee H,Graves R,Chopra N,Sasisekharan R,Lippman M,Petricoin EF3rd,Dadachova E,Lisanti MP,Scherer PE.Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment..J Clin Invest2005;115:1163-76 PMCID:PMC1077173

[61] Park J.Adipocyte-derived endotrophin promotes malignant tumor progression..J Clin Invest2012;122:4243-56 PMCID:PMC3484450

[62] Barsky SH,Grotendorst GR.Increased content of Type V Collagen in desmoplasia of human breast carcinoma..Am J Pathol1982;108:276-83

[63] Vargas AC,Waddell N,Reid LE,Cocciardi S,Song S,Simpson PT.Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression..Breast Cancer Res Treat2012;135:153-65

[64] Eisinger-Mathason TS,Qiu Q,Nakazawa MS,Mucaj V,Stangenberg L,Puré E,Kirsch DG.Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis..Cancer Discov2013;3:1190-205 PMCID:PMC3822914

[65] Januchowski R,Rucinski M,Zabel M.Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line..Biomed Res Int2014;2014:365867 PMCID:PMC3996316

[66] Casey T,Tighe S,Lintault L,Eneman J,White J,Stanley M,Weaver D,Plaut K.Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer..Breast Cancer Res Treat2009;114:47-62

[67] Thomas SS,Li L,Yang P,Rudolph RY,Yan M,Bigler J,Potter JD.Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial..BMC Med Genet2015;16:18 PMCID:PMC4422425

[68] Ting DT,Ligorio M,Shah AM,Aceto N,Brannigan BW,Ciciliano JC,MacKenzie OC,Arora KS,Ellis HL,Bardeesy N,Deshpande V,Kapur R,Shioda T,Maheswaran S.Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells..Cell Rep2014;8:1905-18 PMCID:PMC4230325

[69] Kostourou V.Non-collagenous ECM proteins in blood vessel morphogenesis and cancer..Biochim Biophys Acta2014;1840:2403-13

[70] Ioachim E,Tsanou E,Papadiotis E,Charhanti A,Lampri L.Thrombospondin-1 expression in breast cancer: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components..Histol Histopathol2012;27:209-16

[71] Bondareva A,Ayres F,Boyd SK,Jirik FR.The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells..PLoS One2009;4:e5620

[72] Aoudjit F.Integrin signaling in cancer cell survival and chemoresistance..Chemother Res Pract2012;2012:283181

[73] Hoshiba T.Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages..Biochem Biophys Res Commun2013;439:291-6

[74] Asplund T,Laurent TC.Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts..Cancer Res1993;53:388-92

[75] Knudson W,Toole BP.Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis..Proc Natl Acad Sci U S A1984;81:6767-71 PMCID:PMC392012